About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

DAIKEN MEDICAL CO.,LTD(7775) Financial Results

7775
TSE Standard
DAIKEN MEDICAL CO.,LTD
510
JPY
-8
(-1.54%)
Dec 23, 3:30 pm JST
3.25
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
ー
ー
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2021 7,861 921 957 675 23.5 20 May 14, 2021 J-GAAP
Mar, 2022 8,540 1,150 1,152 831 28.9 20 May 13, 2022 J-GAAP
Mar, 2023 9,137 1,054 1,053 712 24.8 20 May 15, 2023 J-GAAP
Mar, 2024 9,750 1,442 1,450 988 34.4 21 May 15, 2024 J-GAAP
Mar, 2025 Guidance 10,100 1,500 1,500 1,030 35.9 22 May 15, 2024 J-GAAP
YoY +3.6% +4.0% +3.4% +4.3% +4.2%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 9,750 1,711 1,714 1,246 41.6
Fiscal Year Mar, 2024 Mar, 2017 Mar, 2017 Mar, 2017 Mar, 2017
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2021 4,454 585 587 431 15.0 11 May 13, 2022 J-GAAP
Oct - Mar, 2022 4,683 449 448 283 9.9 11 May 15, 2023 J-GAAP
Oct - Mar, 2023 4,926 697 700 451 15.7 12 May 15, 2024 J-GAAP
Oct - Mar, 2024 Guidance 5,186 664 664 422 14.7 13 Oct 31, 2024 J-GAAP
YoY +5.3% -4.7% -5.1% -6.4% -6.5%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Mar, 2022 1,150 937 1,133 -196 -589 2,518 23.06 J-GAAP
Mar, 2023 1,054 779 989 -210 -781 2,516 22.85 J-GAAP
Mar, 2024 1,442 1,387 1,555 -168 -1,163 2,739 24.89 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 4,454 605 605 429 14.9 57.5 Oct 31, 2022 J-GAAP
Apr - Sep, 2023 4,824 745 750 537 18.7 51.7 Oct 31, 2023 J-GAAP
Apr - Sep, 2024 4,914 836 836 608 21.2 55.7 Oct 31, 2024 J-GAAP
YoY +1.9% +12.2% +11.5% +13.2% +13.2%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 2,442 364 363 259 9.0 14.9 Jan 31, 2023 J-GAAP
Jan - Mar, 2023 2,241 85 85 24 0.8 3.8 May 15, 2023 J-GAAP
Apr - Jun, 2023 2,361 339 341 244 8.5 14.4 Jul 31, 2023 J-GAAP
Jul - Sep, 2023 2,463 406 409 293 10.2 16.5 Oct 31, 2023 J-GAAP
Oct - Dec, 2023 2,582 492 492 351 12.2 19.1 Jan 31, 2024 J-GAAP
Jan - Mar, 2024 2,344 205 208 100 3.5 8.7 May 15, 2024 J-GAAP
Apr - Jun, 2024 2,395 397 398 289 10.1 16.6 Jul 31, 2024 J-GAAP
Jul - Sep, 2024 2,519 439 438 319 11.1 17.4 Oct 31, 2024 J-GAAP
YoY +2.3% +8.1% +7.1% +8.9% +8.9%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 2,582 501 501 364 12.2
Fiscal Year Dec, 2023 Dec, 2015 Dec, 2015 Dec, 2016 Dec, 2023
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Mar, 2022 224.13 59.0 10,920 6,438 7,368 0.45 May 13, 2022 J-GAAP
Mar, 2023 228.91 59.7 11,013 6,576 7,506 0.41 May 15, 2023 J-GAAP
Mar, 2024 243.32 63.5 11,006 6,990 7,920 0.30 May 15, 2024 J-GAAP
Apr - Sep, 2024 ー 63.7 11,388 7,254 8,184 0.34 Oct 31, 2024 J-GAAP